文献速递青光眼

学术医院监狱囚犯青光眼诊疗情况

Glaucoma Care of Prison Inmates at an Academic Hospital.
PubMed 文献 · JAMA Ophthalmol · 2020-01-01

这项回顾性队列研究分析了2013至2017年在芝加哥伊利诺伊大学学术眼科中心接受治疗的82名男性囚犯患者(161只眼,375次就诊)的青光眼诊疗情况。研究发现,尽管囚犯用药和就诊在理论上受监狱管控,但70.0%接受治疗的患者报告至少一次用药不依从,仅26.6%的复诊在推荐随访时间内完成,93次就诊延迟超过推荐时间1个月以上。

要点

  • 82名男性囚犯患者中,原发性开角型青光眼和可疑原发性开角型青光眼最常见,分别占53眼和52眼。
  • 接受药物治疗的患者中,70.0%报告至少一次用药不依从,使用4种滴眼液者不依从比例更高。
  • 仅26.6%的复诊在推荐随访时间内完成,34.8%的就诊延迟超过推荐时间1个月以上。

核心结论

  • 尽管监狱环境理论上可管控用药和就诊,囚犯患者中仍存在显著的用药不依从和随访不依从。

研究设计与样本

  • 共分析161只眼、375次就诊的数据,所有患者均为男性,年龄20至75岁(平均50.8岁,标准差11.9岁)。

主要发现

  • 最常见诊断为原发性开角型青光眼(53眼,32.9%)和可疑原发性开角型青光眼(52眼,32.3%)。
  • 77只眼中,青光眼严重程度为轻度者25眼(32.5%),晚期者41眼(53.2%)。
  • 59名患者(73.2%)接受药物治疗,其中40.0%使用最多4种局部滴眼液。
  • 接受治疗的患者中,70.0%(95%CI,57.7%-81.2%)报告至少一次用药不依从。

关键数值与推荐

  • 15只眼接受了17次切开性青光眼手术,包括青光眼引流装置植入(11次,64.7%)和小梁切除术(3次,17.6%)。
  • 仅26.6%的复诊(95%CI,21.3%-32.3%)在推荐随访时间内完成。
  • 93次就诊(34.8%;95%CI,28.2%-40.0%)在推荐随访时间后超过1个月才进行。

临床怎么用

  • 对囚犯青光眼患者应特别关注用药不依从风险,尤其是使用多种局部药物或晚期病变者。
  • 需加强随访管理,因超过三分之一的复诊延迟超过推荐时间1个月以上。

局限性

  • 本研究为单中心回顾性队列研究,样本仅82名男性囚犯患者,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Glaucoma care for prison inmates is underrepresented in the literature even though managing the treatment of such patients may provide unique challenges. OBJECTIVES: To evaluate the glaucoma profile of prison inmates treated at an academic ophthalmology center and to report on the medical and surgical management and follow-up metrics. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study assessed data from 82 incarcerated patients treated at the glaucoma clinic, an academic referral center at the University of Illinois at Chicago, between January 2013 and December 2017. MAIN OUTCOMES AND MEASURES: Diagnosis, glaucoma severity, medical and surgical interventions, and patient-reported medication adherence were recorded for each visit. Recommended and actual follow-up times were recorded and compared. Data analyses were conducted from January 2013 to December 2018. RESULTS: In total, 82 patients (161 eyes) had 375 visits during the study period. All patients were male and ranged from 20 to 75 years of age (mean [SD] age, 50.8 [11.9] years). Most participants were black patients (65 [79.3%]). The most common diagnoses were primary open-angle glaucoma (POAG; 53 eyes [32.9%]) and POAG suspect (52 eyes [32.3%]). Glaucoma severity ranged from mild (25 of 77 eyes [32.5%]) to advanced (41 of 77 eyes [53.2%]). Overall, 59 patients (73.2%) were treated medically with up to 4 topical agents (40.0%). Of those treated, 70.0% of patients (95% CI, 57.7%-81.2%) reported medication nonadherence during at least 1 visit. Medication nonadherence was more common among those taking 4 different topical medications (21 of 24 [87.5%]) compared with others taking fewer medications (20 of 35 [57.1%]), for a difference of 30.4% (95% CI, 7.0%-53.6%; P = .02), and among those with advanced disease (22 of 26 [84.6%]) compared with glaucoma suspect (6 of 13 [46.2%]), for a difference of 38.4% (95% CI, 9.3%-67.5%; P = .02). Nineteen office procedures, including laser peripheral iridotomy and laser trabeculoplasty, were performed on 14 eyes. Seventeen incisional glaucoma procedures were performed on 15 eyes, including glaucoma drainage device implant (11 procedures [64.7%]) and trabeculectomy (3 procedures [17.6%]). Only 26.6% of return office visits (95% CI, 21.3%-32.3%) occurred within the recommended follow-up time frame. Furthermore, 93 patients (34.8%; 95% CI, 28.2%-40.0%) were seen more than 1 month after the recommended follow-up. CONCLUSIONS AND RELEVANCE: Despite incarceration in prison, where medication administration and appointment attendance are theoretically controlled, the results of this study suggested that substantial medication and follow-up nonadherence exists among inmates.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kanu LN, Jang I, Oh DJ, et al. Glaucoma Care of Prison Inmates at an Academic Hospital. JAMA Ophthalmol. 2020. PMID: 32077908. doi:10.1001/jamaophthalmol.2020.0001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。